PL2238974T3 - Granulat do stosowania w preparatach tabletek ulegających rozpadowi w ustach - Google Patents

Granulat do stosowania w preparatach tabletek ulegających rozpadowi w ustach

Info

Publication number
PL2238974T3
PL2238974T3 PL09425135T PL09425135T PL2238974T3 PL 2238974 T3 PL2238974 T3 PL 2238974T3 PL 09425135 T PL09425135 T PL 09425135T PL 09425135 T PL09425135 T PL 09425135T PL 2238974 T3 PL2238974 T3 PL 2238974T3
Authority
PL
Poland
Prior art keywords
granulate
formulation
orodispersible tablets
orodispersible
tablets
Prior art date
Application number
PL09425135T
Other languages
English (en)
Inventor
Massimiliano Rossi
Riccardo Catalano
Silvia Boschetti
Paolo Andreatta
Original Assignee
E Pharma Trento S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40909993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2238974(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by E Pharma Trento S P A filed Critical E Pharma Trento S P A
Publication of PL2238974T3 publication Critical patent/PL2238974T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/16—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by suspending the powder material in a gas, e.g. in fluidised beds or as a falling curtain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
PL09425135T 2009-04-09 2009-04-09 Granulat do stosowania w preparatach tabletek ulegających rozpadowi w ustach PL2238974T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09425135.2A EP2238974B9 (en) 2009-04-09 2009-04-09 Granulate for the formulation of orodispersible tablets

Publications (1)

Publication Number Publication Date
PL2238974T3 true PL2238974T3 (pl) 2013-09-30

Family

ID=40909993

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09425135T PL2238974T3 (pl) 2009-04-09 2009-04-09 Granulat do stosowania w preparatach tabletek ulegających rozpadowi w ustach

Country Status (10)

Country Link
US (3) US20100260854A1 (pl)
EP (1) EP2238974B9 (pl)
CA (1) CA2697576C (pl)
CY (1) CY1114183T1 (pl)
DK (1) DK2238974T3 (pl)
ES (1) ES2422281T3 (pl)
HR (1) HRP20130805T2 (pl)
PL (1) PL2238974T3 (pl)
PT (1) PT2238974E (pl)
SI (1) SI2238974T1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2238974E (pt) * 2009-04-09 2013-07-09 E Pharma Trento Spa Granulado para a formulação de comprimidos orodispersíveis
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622719A (en) 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
DE19615418A1 (de) * 1996-04-22 1997-10-23 Merck Patent Gmbh Polyol-Zusammensetzung
ES2263216T3 (es) 1997-07-25 2006-12-01 Alpex Pharma S.A. Procedimiento para la preparacion de un granulado adecuado para la preparacion de comprimidos solubles en la boca rapidamente disgregables.
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
FR2787110B1 (fr) * 1998-12-11 2001-02-16 Roquette Freres Sorbitol pulverulent et son procede de preparation
NZ512166A (en) * 2001-06-01 2003-09-26 Marketing Brokers Nz Ltd Wax applicator with a cylindrical roller having convex ends.
EP1279402B1 (en) 2001-07-26 2006-11-29 Ethypharm Coated granules of allylamine-or benzylamine-anti-mycotics, process for preparation thereof and orodispersible tablets containing said coated granules
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FI20021312L (fi) * 2002-07-03 2004-01-04 Danisco Sweeteners Oy Polyolikoostumusten kiteyttäminen, kiteinen polyolikoostumustuote ja sen käyttö
KR101232114B1 (ko) * 2004-08-12 2013-02-13 레킷트 벵키저 헬스케어(유케이)리미티드 용융 압출에 의해 제조된, 파라세타몰, ｎｓａｉｄ 및 당알콜 함유 과립
FR2894475B1 (fr) 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
US20070212417A1 (en) * 2006-03-07 2007-09-13 Cherukuri S R Compressible resilient granules and formulations prepared therefrom
FR2898492B1 (fr) 2006-03-15 2008-06-06 Pierre Fabre Medicament Sa Comprimes orodispersibles de domperidone
KR20100033400A (ko) * 2007-06-06 2010-03-29 바스프 에스이 급속 붕해 정제의 제조를 위한 제약 제제
PT2238974E (pt) * 2009-04-09 2013-07-09 E Pharma Trento Spa Granulado para a formulação de comprimidos orodispersíveis

Also Published As

Publication number Publication date
ES2422281T3 (es) 2013-09-10
US20160045438A1 (en) 2016-02-18
SI2238974T1 (sl) 2013-09-30
PT2238974E (pt) 2013-07-09
DK2238974T3 (da) 2013-08-26
CY1114183T1 (el) 2016-08-31
US10632073B2 (en) 2020-04-28
US9861581B2 (en) 2018-01-09
EP2238974B9 (en) 2014-05-21
CA2697576C (en) 2017-07-11
EP2238974A1 (en) 2010-10-13
HRP20130805T2 (en) 2013-10-11
US20100260854A1 (en) 2010-10-14
US20180092849A1 (en) 2018-04-05
EP2238974B1 (en) 2013-06-05
HRP20130805T1 (en) 2013-09-30
CA2697576A1 (en) 2010-10-09

Similar Documents

Publication Publication Date Title
SMT201800564T1 (it) Formulazioni in compressa a rilascio immediato
ZA201200719B (en) Pharmaceutical formulation
SI3061445T1 (sl) Visoko koncentrirane farmacevtske formulacije
HUE044981T2 (hu) Gyógyszerkészítmény
EP2379077A4 (en) PHARMACEUTICAL COMPOSITION
IL220097A (en) Pharmaceutical preparation containing oligopeptides
GB0907003D0 (en) Formulation
IL208788A (en) Pharmacy-based formulation
ZA201104670B (en) Pharmaceutical composition comprising aleglitazar
HRP20130805T2 (en) Granulate for the formulation of orodispersible tablets
LT2391352T (lt) Farmacinės veikliųjų medžiagų atpalaidavimo formos
EP2473168A4 (en) PHARMACEUTICAL FORMULATIONS FOR INDIBULIN
PL2651390T3 (pl) Orodyspersyjna tabletka farmaceutyczna na bazie zolpidemu
GB0919650D0 (en) Pharmaceutical composition
GB0911213D0 (en) Formulation
GB0907410D0 (en) Formulation
GB0805292D0 (en) Pharmaceutical formulation
GB0920790D0 (en) Pharmaceutical agent
GB0905555D0 (en) Pharmaceutical agent
GB0905557D0 (en) Pharmaceutical agent
GB0905558D0 (en) Pharmaceutical agent
GB0910754D0 (en) Pharmaceutical agent
GB0913956D0 (en) Pharmaceutical agent
GB0810217D0 (en) Pharmaceutical formulations
GB0813031D0 (en) Pharmaceutical formulations